|28 1 Suppl 1 : S24-9||NIOSH pocket guide to chemical hazards|
|"Aspirin and cancer risk: a quantitative review to 2011"||International Journal of Food Properties|
"Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat".8
|Proceedings of the National Academy of Sciences of the United States of America||"Darvon poisoning with delayed salicylism: a case report"|
|"Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U||"Secondary prevention of coronary artery disease"|
"Does aspirin acetylate multiple cellular proteins? Significance of measurements of salicylate in blood in cases of acute ingestion".
|US Preventive Services Task Force||"2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism"|
|"Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks"||"Antiplatelet agents in secondary prevention of stroke: a perspective"|
"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation".